{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:53Z","timestamp":1787032793237,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"DOI":"10.7759\/cureus.32858","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:53:01Z","timestamp":1671774781000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Intravenous Anti-hypertensives for Preoperative Blood Pressure Control in Hypertensive Disorders of Pregnancy and Effect of Oral Labetalol"],"prefix":"10.7759","author":[{"given":"Ranju","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2010.12.001","article-title":"A critical analysis of maternal morbidity and mortality in Liberia, West Africa","volume":"28","author":"Lori JR","year":"2012","unstructured":"Lori JR, Starke AE. A critical analysis of maternal morbidity and mortality in Liberia, West Africa. Midwifery. 2012, 28:67-72. 10.1016\/j.midw.2010.12.001","journal-title":"Midwifery"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.56231","article-title":"Use of magnesium sulfate to manage pre-eclampsia and eclampsia in Nigeria: overcoming the odds","volume":"8","author":"Ekele BA","year":"2009","unstructured":"Ekele BA. Use of magnesium sulfate to manage pre-eclampsia and eclampsia in Nigeria: overcoming the odds. Ann Afr Med. 2009, 8:73-5. 10.4103\/1596-3519.56231","journal-title":"Ann Afr Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125749","article-title":"Criteria-based audit of quality of care to women with severe pre-eclampsia and eclampsia in a referral hospital in Accra, Ghana","volume":"10","author":"Browne JL","year":"2015","unstructured":"Browne JL, van Nievelt SW, Srofenyoh EK, Grobbee DE, Klipstein-Grobusch K. Criteria-based audit of quality of care to women with severe pre-eclampsia and eclampsia in a referral hospital in Accra, Ghana. PLoS One. 2015, 10:e0125749. 10.1371\/journal.pone.0125749","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy","volume":"183","year":"2000","unstructured":"Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000, 183.1-22. 10.1067\/mob.2000.107928","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley L","year":"2002","unstructured":"Duley L, Henderson-Smart DJ. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2002, CD001449. 10.1002\/14651858.CD001449","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4172\/2167-0420.1000200","article-title":"A comparison of hydralazine and labetalol in the management of severe preeclampsia","volume":"3","author":"Nombur LI","year":"2014","unstructured":"Nombur LI, Agida ET, Isah AY, Ekele BA. A comparison of hydralazine and labetalol in the management of severe preeclampsia. J Women\u2019s Health Care. 2014, 3:6. 10.4172\/2167-0420.1000200","journal-title":"J Women\u2019s Health Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2013.08.001","article-title":"Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial","volume":"4","author":"Delgado De Pasquale S","year":"2014","unstructured":"Delgado De Pasquale S, Velarde R, Reyes O, De La Ossa K. Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial. Pregnancy Hypertens. 2014, 4:19-22. 10.1016\/j.preghy.2013.08.001","journal-title":"Pregnancy Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20182330","article-title":"A comparative study of hydralazine versus labetalol in the management of pregnancy induced hypertension (PIH)","volume":"4","author":"Nabanita D","year":"2016","unstructured":"Nabanita D, Das GC, Swagata B, Sangeeta Y. A comparative study of hydralazine versus labetalol in the management of pregnancy induced hypertension (PIH). Sch J App Med Sci. 2016, 4:3996-3999. 10.18203\/2320-1770.ijrcog20182330","journal-title":"Sch J App Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.332.12243","article-title":"Comparison of hydralazine and labetalol to lower severe hypertension in pregnancy","volume":"33","author":"Khan A","year":"2017","unstructured":"Khan A, Hafeez S, Nasrullah FD. Comparison of hydralazine and labetalol to lower severe hypertension in pregnancy. Pak J Med Sci. 2017, 33:466-70. 10.12669\/pjms.332.12243","journal-title":"Pak J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee LA","year":"2008","unstructured":"Magee LA, Helewa M, Rey E; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008, 30:1-2. 10.1016\/S1701-2163(16)32776-1","journal-title":"J Obstet Gynaecol Can"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15406\/ogij.2017.06.00222","article-title":"Intravenous hydrallazine or intravenous labetalol in severe hypertension in pregnancy: a randomized clinical trial","volume":"6","author":"Mmom CF","year":"2017","unstructured":"Mmom CF, Ogu RN, Orazulike NC, Uzoigwe SA. Intravenous hydrallazine or intravenous labetalol in severe hypertension in pregnancy: a randomized clinical trial. Obstet Gynecol Int J. 2017, 6:00222. 10.15406\/ogij.2017.06.00222","journal-title":"Obstet Gynecol Int J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/10641950701204430","article-title":"Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial","volume":"26","author":"Vigil-De Gracia P","year":"2007","unstructured":"Vigil-De Gracia P, Ruiz E, L\u00f3pez JC, de Jaramillo IA, Vega-Maleck JC, Pinz\u00f3n J. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy. 2007, 26:163-71. 10.1080\/10641950701204430","journal-title":"Hypertens Pregnancy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4314\/nmp.v53i6.28935","article-title":"Preeclampsia: a study of risk factors","volume":"53","author":"Omole-Ohonsi A","year":"2008","unstructured":"Omole-Ohonsi A, Ashimi AO. Preeclampsia: a study of risk factors. Niger Med Pract. 2008, 53:99-102. 10.4314\/nmp.v53i6.28935","journal-title":"Niger Med Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S77344","article-title":"Current best practice in the management of hypertensive disorders in pregnancy","volume":"9","author":"Townsend R","year":"2016","unstructured":"Townsend R, O'Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016, 9:79-94. 10.2147\/IBPC.S77344","journal-title":"Integr Blood Press Control"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12081115","article-title":"Preeclampsia: Updates in pathogenesis, definitions, and guidelines","volume":"11","author":"Phipps E","year":"2016","unstructured":"Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: Updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016, 11:1102-13. 10.2215\/CJN.12081115","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2010.08.011","article-title":"Spinal anesthesia for lower segment Cesarean section in patients with stable eclampsia","volume":"23","author":"Singh R","year":"2011","unstructured":"Singh R, Kumar N, Jain A, Chakraborty M. Spinal anesthesia for lower segment Cesarean section in patients with stable eclampsia. J Clin Anesth. 2011, 23:202-6. 10.1016\/j.jclinane.2010.08.011","journal-title":"J Clin Anesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah L","year":"2012","unstructured":"Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia\/eclampsia. Semin Perinatol. 2012, 36:56-9. 10.1053\/j.semperi.2011.09.011","journal-title":"Semin Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/63932-comparison-of-intravenous-anti-hypertensives-for-preoperative-blood-pressure-control-in-hypertensive-disorders-of-pregnancy-and-effect-of-oral-labetalol","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:52:51Z","timestamp":1707490371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/63932-comparison-of-intravenous-anti-hypertensives-for-preoperative-blood-pressure-control-in-hypertensive-disorders-of-pregnancy-and-effect-of-oral-labetalol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.32858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,23]]}}}